Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 86.00
Change Today +5.42 / 6.73%
Volume 31.9K
NXGN On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 5:44 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

132 Menahen Begin

Migdaleyi Azrieli

Tel Aviv, 67021

Israel

Phone: 972 3 607 0320

Fax: 972 3 607 0323

Nextgen Biomed Ltd develops drugs for topical treatments for skin diseases. It develops DPS-101, a product that is in the Phase II/b used for the topical treatment of psoriasis without steroids. Nextgen Biomed Ltd has a collaboration agreement with the Boston VA Research Institute Inc. for the realization of Phase II and III of clinical experiments in human beings of DPS. The Company was incorporated in 1990 and is based in Tel Aviv, Israel.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXGN:IT 86.00 +5.42

NXGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NXGN.
View Industry Companies
 

Industry Analysis

NXGN

Industry Average

Valuation NXGN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXTGEN BIOMED LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.